Eczema Free Foreverâ„¢ Eczema Free Foreverâ„¢

Methotrexate outperforms cyclosporine in atopic dermatitis study

The duration of methotrexate administration proves to be longer than that of cyclosporine in atopic dermatitis, according to a small study that compared the two first-line immunosuppressive treatments for atopic dermatitis.
Dermatology Times – Dermatology

Ustekinumab shows promise for reducing psoriasis-associated cardiovascular comorbidity

Initial results of an investigator-initiated phase 4 trial suggest that blocking interleukin-12 (IL-12) and IL-23 may reduce cardiovascular inflammation associated with psoriasis, researchers reported at AAD 2018.
Dermatology Times – Dermatology